G. MASON MORFIT is a Partner, the Chief Executive Officer and Chief Investment Officer of ValueAct Capital and is a member of the firm’s Management Committee. Mr. Morfit is a former director of Advanced Medical Optics, Inc., C.R. Bard, Inc., Immucor, Inc., Microsoft Corporation, MSD Performance, Inc., Solexa, Inc. and Valeant Pharmaceuticals International. Prior to joining ValueAct Capital at inception, Mr. Morfit worked in equity research for Credit Suisse First Boston’s health care group where he focused on the managed care industry. Mr. Morfit has lectured on issues of corporate governance and executive compensation at Stanford Law School’s Director’s College, the Graduate School of Business at Stanford University, and the Haas School of Business at the University of California, Berkeley. Mr. Morfit is a member of the Advisory Council for Princeton University’s Woodrow Wilson School of Public and International Affairs and serves on the Board of Directors of the Tipping Point Community. He has a B.A. from Princeton University and is a CFA charterholder.
Past & Present Board Affiliations